Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis

Alexi Vasbinder, YeeAnn Chen, Adrien Procureur, Allison Gradone, Tariq U. Azam, Daniel Perry, Husam Shadid, Elizabeth Anderson, Tonimarie Catalan, Pennelope Blakely, Namratha Nelapudi, Mohamad Fardous, Marie C. Bretagne, Sarah K. Adie, Kristen T. Pogue, Monika Leja, Sarah Yentz, Bryan Schneider, Leslie A. Fecher, Christopher D. Lao, Joe-Elie Salem, Salim S. Hayek

Open source

DOI: 10.1016/j.jaccao.2022.11.004
Published: 2022-12
Container: JACC: CardioOncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jaccao.2022.11.004,
  title = {Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis},
  author = {Alexi Vasbinder and YeeAnn Chen and Adrien Procureur and Allison Gradone and Tariq U. Azam and Daniel Perry and Husam Shadid and Elizabeth Anderson and Tonimarie Catalan and Pennelope Blakely and Namratha Nelapudi and Mohamad Fardous and Marie C. Bretagne and Sarah K. Adie and Kristen T. Pogue and Monika Leja and Sarah Yentz and Bryan Schneider and Leslie A. Fecher and Christopher D. Lao and Joe-Elie Salem and Salim S. Hayek},
  year = {2022},
  journal = {JACC: CardioOncology},
  doi = {10.1016/j.jaccao.2022.11.004},
  url = {https://doi.org/10.1016/j.jaccao.2022.11.004}
}

RIS

TY  - JOUR
TI  - Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis
AU  - Alexi Vasbinder
AU  - YeeAnn Chen
AU  - Adrien Procureur
AU  - Allison Gradone
AU  - Tariq U. Azam
AU  - Daniel Perry
AU  - Husam Shadid
AU  - Elizabeth Anderson
AU  - Tonimarie Catalan
AU  - Pennelope Blakely
AU  - Namratha Nelapudi
AU  - Mohamad Fardous
AU  - Marie C. Bretagne
AU  - Sarah K. Adie
AU  - Kristen T. Pogue
AU  - Monika Leja
AU  - Sarah Yentz
AU  - Bryan Schneider
AU  - Leslie A. Fecher
AU  - Christopher D. Lao
AU  - Joe-Elie Salem
AU  - Salim S. Hayek
PY  - 2022
JO  - JACC: CardioOncology
DO  - 10.1016/j.jaccao.2022.11.004
UR  - https://doi.org/10.1016/j.jaccao.2022.11.004
ER  -

APA

Vasbinder, A., Chen, Y., Procureur, A., Gradone, A., Azam, T. U., Perry, D., Shadid, H., Anderson, E., Catalan, T., Blakely, P., Nelapudi, N., Fardous, M., Bretagne, M. C., Adie, S. K., Pogue, K. T., Leja, M., Yentz, S., Schneider, B., Fecher, L. A., Lao, C. D., Salem, J., & Hayek, S. S. (2022). Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis. JACC: CardioOncology. https://doi.org/10.1016/j.jaccao.2022.11.004

Source records

crossref · retrieved 2026-09-26T13:33:14.634Z